Follow-The-Filings

Security

Apellis Pharmaceuticals Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

15 owners 2 new max 0.5% (George Soros - Soros Fund...)

owners 15
max % 0.5%
tracked value $797M
qoq N 2 A 5 R 6

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
George Soros - Soros Fund Management LLC 2026 Q1 0.5% New 0.5% 1,056,000 $42M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.2% Add +0.20 pp 4,183,918 $168M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.1% Add +0.10 pp 1,917,501 $77M hist
Renaissance Technologies LLC 2026 Q1 0.1% Add +0.03 pp 935,958 $38M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add +0.03 pp 2,256,802 $91M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce +0.01 pp 929,019 $37M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.02 pp 562,361 $14M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce -0.02 pp 427,970 $17M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.0% Reduce -0.01 pp 78,750 $3M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.0% Reduce -0.01 pp 34,913 $1M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 10,674,865 $268M hist
Norges Bank 2025 Q4 stale 0.0% Exit 0.00 pp 1,198,444 $30M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 186,853 $8M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 38,887 $2M hist
Farallon Capital Management LLC 2026 Q1 0.0% New 0.0% 6,000 $241 hist

ownership over time

filing count by report period · click a bar for that quarter’s holders